Edition:
United States

Oxford BioMedica PLC (OXB.L)

OXB.L on London Stock Exchange

4.28GBp
23 Jan 2017
Change (% chg)

0.06 (+1.54%)
Prev Close
4.22
Open
4.28
Day's High
4.28
Day's Low
4.28
Volume
128,431
Avg. Vol
4,624,332
52-wk High
7.87
52-wk Low
2.98

OXB.L

Chart for OXB.L

About

Oxford BioMedica plc is a gene and cell therapy company. The Company is engaged in lentiviral vector and cell therapy research, development and production. The Company's segments include Partnering, and R&D. The Partnering segment provides lentiviral vector bioprocessing and process development services to partners. The R&D... (more)

Overall

Beta: 0.49
Market Cap(Mil.): £130.16
Shares Outstanding(Mil.): 3,088.05
Dividend: --
Yield (%): --

Financials

  OXB.L Industry Sector
P/E (TTM): -- 44.85 30.38
EPS (TTM): -0.01 -- --
ROI: -43.95 -1.38 14.86
ROE: -122.72 -1.07 16.28

BRIEF-Oxford Biomedica inks strategic alliance with Orchard Therapeutics

* Oxford Biomedica announces a strategic alliance with Orchard Therapeutics

Nov 29 2016

Earnings vs. Estimates